Andrea Lejay

Andrea Lejay, a key figure in our business law division, specializes in corporate and securities law. She offers her expertise to both publicly traded and privately held entities, guiding them through the intricacies of corporate finance, mergers and acquisitions (M&A), and regulatory adherence to securities laws.

Her role in corporate finance includes guiding companies through the initial stages of going public, managing prospectus offerings, orchestrating private investments, and overseeing rights distributions. Andrea skillfully negotiates on behalf of businesses and underwriters alike, ensuring their interests are well-represented.

When it comes to mergers and acquisitions, Andrea's prowess shines as she brokers deals between acquiring firms and their targets, facilitating smooth transitions in business combinations, asset acquisitions, and divestitures across both public and private sectors.

Andrea's expertise extends into the realm of securities regulation, where she aids public companies in fulfilling ongoing disclosure obligations, maintaining corporate governance standards, adhering to mineral disclosure rules, seeking exemptions, and liaising with securities regulators.

She is instrumental in drafting and negotiating shareholder and joint venture agreements, helping clients establish and maintain profitable commercial partnerships.

Before her tenure with our firm, Andrea honed her skills at a prominent national law practice. Her educational background is solid, with a J.D. and a B.A. from the University of British Columbia, earned in 2014 and 2010, respectively. She was admitted to the British Columbia bar in 2015.

Andrea's professional journey is marked by significant contributions to various sectors, including energy, technology, life sciences, and healthcare. She played a pivotal role in some noteworthy transactions, such as the sale of Benevity, Inc. to HG Capital LLP, a deal that stands out as one of Canada's largest in the software sector. Her involvement in the acquisition of a majority stake in the Waneta Expansion Hydroelectric Project by Columbia Power Corporation and Columbia Basin Trust, valued at around C$1 billion, showcases her adeptness in handling large-scale deals.

In the pharmaceutical industry, Andrea facilitated the sale of Vanrx Pharmasystems Inc. to Cytiva, part of the Danaher group, highlighting her versatility across industries. Her work with mining companies in acquiring royalties and mineral properties further underscores her comprehensive expertise.

In corporate finance, Andrea has represented underwriters in significant public offerings, like the C$172-million IPO of BBTV Holdings Inc., and has been instrumental in private placements and financing rounds for companies like Ely Gold Royalties Inc. and Zucara Therapeutics Inc.

Her involvement in private equity includes advising fund managers on restructurings, capital raising initiatives, and the amendment of foundational documents, showcasing her broad skill set and adaptability to diverse legal challenges.